Assessment of Monitoring and Management Practices of Antipsychotic-Induced Hyperprolactinemia at a Medical City in Riyadh, Saudi Arabia: A Retrospective Cohort Study
CONCLUSION: It is imperative to conduct a baseline check of prolactin levels before commencing any antipsychotic therapy. Similarly, routine prolactin level monitoring is recommended regardless of symptoms in patients treated with antipsychotics with a possible prolactin-raising effect. Adherence to evidence-based treatment guidelines can improve patient quality of life and therapeutic compliance.PMID:38485677 | DOI:10.2174/0115748863280407240305070905
Source: Current Drug Safety - Category: Drugs & Pharmacology Authors: Zahra Hussain Alshabeeb Bashayr Alsuwayni Omar Alshargi Ahmed H Abdelazeem Source Type: research
More News: Abilify | Academia | Bipolar | Drugs & Pharmacology | Mania | Middle East Health | Psychiatry | Saudi Arabia Health | Study